X

BACTROBAN NASAL OINTMENT 2% W/W

Product Information

Registration Status: Active

SIN05075P

BACTROBAN NASAL OINTMENT 2% W/W is approved to be sold in Singapore with effective from 1990-09-17. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN05075P.

This product contains Mupirocin 2% w/w in the form of OINTMENT. It is approved for NASAL use.

This product is manufactured by Glaxo Operations UK LTD (trading as Glaxo Wellcome Operations) in UNITED KINGDOM.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Product Reference
Loading...


Description

Mupirocin (pseudomonic acid A, or Bactroban or Centany) is an antibiotic originally isolated from Pseudomonas fluorescens. It is used topically, and is primarily effective against Gram-positive bacteria. Mupirocin is bacteriostatic at low concentrations and bactericidal at high concentrations. Mupirocin has a unique mechanism of action, which is selective binding to bacterial isoleucyl-tRNA synthetase, which halts the incorporation of isoleucine into bacterial proteins. Because this mechanism of action is not shared with any other antibiotic, mupirocin has few problems of antibiotic cross-resistance.

Indication

For the treatment of Staphylococci nasal carriers.

Mechanism of Action

Mupirocin reversibly binds to bacterial isoleucyl-tRNA synthetase, an enzyme which promotes the conversion of isoleucine and tRNA to isoleucyl-tRNA. Prevention of this enzymes from functioning properly results in the inhibition of bacterial protein and RNA synthesis.

Pharmacokinetics

Absorption
No measurable systemic absorption
Distribution
Metabolism
Hepatic. Following intravenous or oral administration, mupirocin is rapidly metabolized. The principal metabolite is monic acid, which has no antibacterial activity.
Elimination

Active Ingredient/Synonyms

9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid | Mupirocina | Mupirocine | Mupirocinum | Pseudomonic acid | Pseudomonic acid a | Mupirocin |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank

Pharmfair.com uses cookies to improve your browsing experience. We'll assume you're ok with this, but you can opt-out if you wish. Peace!